Celgene Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Celgene Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments
- Intelligence on Celgene Corporation’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celgene Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Celgene, an integrated biopharmaceutical company, discovers, develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company primarily operates in the US. The company is headquartered in Summit, New Jersey and employed 4,182 people as of December 31, 2010. The company recorded revenues of $3,625.7 million during the financial year (FY) ended December 2010, an increase of 34.8% over FY2009. The operating profit of the company was $989.6 million during FY2010, an increase of 17.6% over FY2009. The net profit was $880.5 million in FY2010, an increase of 13.4% over FY2009.

Reasons to Purchase:

- Gain understanding of Celgene Corporation and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Celgene Corporation as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers businesses better
- Stay up to date on Celgene Corporation’s business structure, strategy and prospects

Company Snapshot
Celgene Corporation: Company Overview
Celgene Corporation: Overview and Key Facts
Celgene Corporation: Overview
Celgene Corporation: Key Facts
Celgene Corporation: Key Employees
Celgene Corporation: Key Employee Biographies
Celgene Corporation: Major Products and Services
Celgene Corporation: Company History
Celgene Corporation: Management Statement
Celgene Corporation: Locations and Subsidiaries
Celgene Corporation: Key Competitors
Celgene Corporation: Company Analysis
Celgene Corporation: Business Description
Celgene Corporation: SWOT Analysis
Celgene Corporation: SWOT Overview
Celgene Corporation: Strengths
Celgene Corporation: Weaknesses
Celgene Corporation: Opportunities
Celgene Corporation: Threats
Celgene Corporation: Corporate Financial Deals Activity
Celgene Corporation: Financial Deals Overview
Celgene Corporation: Targets and Partners
Celgene Corporation: Top Deals 2007 -YTD*2011
Celgene Corporation: Advisors
Celgene Corporation: Top Legal Advisors
Celgene Corporation: Top Financial Advisors
Celgene Corporation: Mergers and Acquisitions
Celgene Corporation: Corporate Venturing
Celgene Corporation: Partnership
Celgene Corporation: Recent Developments
Celgene Corporation: News and Events Summary
Celgene Corporation: Corporate Governance
Celgene Corporation: Financial Deals
Celgene Corporation: Financial Performance
Celgene Corporation: Regulatory and Legal Events
Celgene Corporation: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Celgene Corporation: Key Facts
Table 2: Celgene Corporation: Key Employees
Table 4: Celgene Corporation: Key Competitors
Table 5: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM)
Table 6: Celgene Corporation: Deal Activity by Deal Type - Volume (2007 - YTD*2011)
Table 7: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Table 8: Celgene Corporation: Targets and Partners
Table 9: Celgene Corporation: Top Deals 2007 -YTD*2011
Table 10: Celgene Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: Celgene Corporation: Financial Advisor Ranking by Value (US$m)
Table 12: Celgene Corporation: M&A Volume and Value Trend (2007 - YTD*2011)
Table 13: Celgene Corporation: M&A Activity by Geography (2007 - YTD*2011)
Table 14: Celgene Corporation: Corporate Venturing Volume and Value Trend (2007 - YTD*2011)
Table 15: Celgene Corporation: Corporate Venturing by Geography (2007 - YTD*2011)
Table 16: Celgene Corporation: Partnership Volume and Value Trend (2007 - YTD*2011)
Table 17: Celgene Corporation: Partnership Trend by Deal Type (2007 - YTD*2011)
Table 18: Celgene Corporation: News and Events Summary
Table 19: Celgene Corporation: Corporate Governance
Table 20: Celgene Corporation: Financial Deals
Table 21: Celgene Corporation: Financial Performance
Table 22: Celgene Corporation: Regulatory and Legal Events
Table 23: Celgene Corporation: Research & Development

List of Figures

Figure 1: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM)
Figure 2: Celgene Corporation: Deal Activity by Deal Type - Volume (2007 - YTD*2011)
Figure 3: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Figure 4: Celgene Corporation: M&A Volume and Value Trend (2007 - YTD*2011)
Figure 5: Celgene Corporation: M&A Activity by Geography (2007 - YTD*2011)
Figure 6: Celgene Corporation: Corporate Venturing Volume and Value Trend (2007 - YTD*2011)
Figure 7: Celgene Corporation: Corporate Venturing by Geography (2007 - YTD*2011)
Figure 8: Celgene Corporation: Partnership Volume and Value Trend (2007 - YTD*2011)
Figure 9: Celgene Corporation: Partnership Trend by Deal Type (2007 - YTD*2011)